Study Results: Aesculap Implant Systems’ activL Artificial Disc
Patient outcomes at seven years post-op compare the activL Artificial Disc with the ProDisc-L to treat single-level lumbar degenerative disc disease. Jul 27, 2021
MiRus Raises $65 Million for Expansion of Rhenium-based Medical Devices
MiRus completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and other solutions using Rhenium-based alloys (MoRe). Jul 27, 2021
NuVasive Launches Modulus ALIF Porous Implant for Anterior Spine Surgery
Modulus ALIF provides implants and instrumentation designed for both supine ALIF and XALIF procedures. Jul 22, 2021
European Study with 5-year Follow-up of Episealer Talus Patients
Episealer Talus is Episurf Medical’s CE Marked joint implant for treatment of osteochondral ankle lesions. Jul 22, 2021
Study Results: REGENETEN Bioinductive Implant in Rotator Cuff Tear
Investigators compared the REGENETEN Implant alone vs. with traditional surgical repair to treat partial-thickness rotator cuff tears. Jul 21, 2021
ORTHOWORLD Launches All-new Orthopedic Supplier Directory and BONEZONE Website to Product Development Engineers
Product development engineers, global sourcing professionals and executives can access education, connections and people to optimize orthopedic product commercialization. Jul 20, 2021
Integrity Implants and Fusion Robotics Merge to Form Accelus
Accelus to offer procedure-enabling technology with the goal of making minimally invasive surgery the standard of care in spine. Jul 16, 2021
Episurf Medical Updates: U.S./European Markets, Talus Study
Among its updates, Episurf is preparing for commercial U.S. launch of the Episealer Patellofemoral System during 2022. Jul 16, 2021
Vivex Biologics Launches VIA Mend Synthetic Bone Fillers
The product can be molded to fill defects and supports an environment for bone growth via two formats: putty and strip. Jul 15, 2021
Active Implants NUsurface Meniscus Study Results
The NUsurface Implant is the first artificial meniscus to be marketed in Europe and is currently under review by FDA. Jul 15, 2021
